Literature DB >> 16927124

Oncogenic Marek's disease viruses lacking the 132 base pair repeats can still be attenuated by serial in vitro cell culture passages.

R F Silva1, Isabel Gimeno.   

Abstract

Marek's disease virus (MDV) can be attenuated by serially passing the virus in cell culture. During cell culture passage, two copies of a 132 bp repeat are expanded to over 30 copies. We deleted the two copies of the 132 bp repeat region in a pathogenic MDV and demonstrated that the virus was still pathogenic. The pattern and frequency of tumors in the parental and mutant virus were the same. Early virus replication, and the appearance of persistent neurological disease were also similar between the parental and deleted virus. Nevertheless, wild-type MDV and the deletion virus could be attenuated by serial in vitro cell culture passages. Based upon analyzing the passage 40 viruses, attenuation of the MDV lacking the 132 bp repeats appears to occur in a manner that is analogous to the process occurring wild-type MDV attenuation. Whatever process is involved in the cell culture attenuation of MDV, the mechanism does not involve the 132 bp repeat region.

Entities:  

Mesh:

Year:  2006        PMID: 16927124     DOI: 10.1007/s11262-006-0022-7

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  12 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation.

Authors:  R F Silva; S M Reddy; B Lupiani
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus.

Authors:  F Peng; G Bradley; A Tanaka; G Lancz; M Nonoyama
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.

Authors:  R F Silva; R L Witter
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

Authors:  B H Rispens; H van Vloten; N Mastenbroek; H J Maas; K A Schat
Journal:  Avian Dis       Date:  1972-04       Impact factor: 1.577

7.  The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA.

Authors:  K Fukuchi; A Tanaka; L W Schierman; R L Witter; M Nonoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function.

Authors:  Sanjay M Reddy; Blanca Lupiani; Isabel M Gimeno; Robert F Silva; Lucy F Lee; Richard L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

9.  Precipitating antigens associated with Marek's disease viruses and a herpesvirus of turkeys.

Authors:  V V Bulow; P M Biggs
Journal:  Avian Pathol       Date:  1975       Impact factor: 3.378

10.  Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage.

Authors:  L J Ferrin; R D Camerini-Otero
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  5 in total

1.  Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes.

Authors:  Taejoong Kim; Jody Mays; Aly Fadly; Robert F Silva
Journal:  Virus Genes       Date:  2011-02-22       Impact factor: 2.332

2.  Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.

Authors:  Stephen J Spatz; Cary A Rue
Journal:  Virus Genes       Date:  2008-03-20       Impact factor: 2.332

3.  Deletion of the Meq gene significantly decreases immunosuppression in chickens caused by pathogenic Marek's disease virus.

Authors:  Yanpeng Li; Aijun Sun; Shuai Su; Peng Zhao; Zhizhong Cui; Hongfei Zhu
Journal:  Virol J       Date:  2011-01-05       Impact factor: 4.099

4.  Deletion of 1.8-kb mRNA of Marek's disease virus decreases its replication ability but not oncogenicity.

Authors:  Aijun Sun; Yanpeng Li; Jingyan Wang; Shuai Su; Hongjun Chen; Hongfei Zhu; Jiabo Ding; Zhizhong Cui
Journal:  Virol J       Date:  2010-10-29       Impact factor: 4.099

5.  Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.

Authors:  Susan J Baigent; Venugopal K Nair; Hervé Le Galludec
Journal:  J Virol Methods       Date:  2016-03-10       Impact factor: 2.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.